1/28
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
MHC = closely linked ___ on chromosome # __
genes; 6
MHC Class 1 proteins
HLA-A, HLA-B, HLA-C
all nucleated cells
MHC class 2 proteins
HLA-DR, HLA-DQ, HLA-DP
pAPCs
Autograft
tissue transfer in same individual
Syngeneic / Isograft
transfer of cells/tissues to a genetically identical individual
Allograft
graft between genetically nonidentical individuals of the same species
Xenograft
transplant between members of different species
Direct vs Indirect Allorecognition
Direct
Tc cells bind foreign HLA Ag and release cytotoxic factors (perforins, granzymes)
Indirect
Host pAPC present foreign MHC Ag on graft to host Th cells
Hyperacute
minutes to hours
Preformed Ab to ABO, HLA, endothelial Ag
bind to vascular endothelium and activate C’ and clotting factors
Accelerated
several days
Preformed Ab to ABO, HLA, endothelial Ag
bind to vascular endothelium and activate C’ and clotting factors
Acute
days to months
Th cytokines produce DTH
CD8 T cells mediate cytotoxicity; Ab bind to C’and induce inflammation
Chronic
1 year or more
DTH (TH cytokines)
GVHD
lymphoid cells in graft mount immune response against host HLA Ag
cytokine release, inflammation, destruction of various tissues
100 days post-transplant
acute/chronic
Corticosteroids
anti-inflammatory
Antimetabolites
interfere with lymphocyte maturation and division
Calcineurin inhibitors
block cytokines synthesis in T cells
Monoclonal Ab
interfere with T/B cell function by binding to lymph surface molecules
Polyclonal Ab
animal-derived Ab against human cells that deplete thymocytes or lymphocytes
HLA Typing - Complement-Dependent Cytotoxicity (CDC)
HLA Ag identified by their reactivity with panels of antisera
Pt serum incubated with panels of lymphs
Anti-human Ig can increase test sensitivity
% panel reactive Ab (%PRA) reported
PCR with Sequence Specific Primers
PCR-SPP
PCR amplification of HLA genes with panels of primer pairs, each of which amplifies specific alleles or related allele groups
PCR-Sequence-Specific-Oligonucleotide-Probe Hybridization
single PCR reaction that will amplify all HLA gene variants at a specific locus (referred to as a generic amplification). The amplified gene is then subjected to hybridization with a panel of DNA probes, each specific for a unique HLA allele or allele group. Only those probes that specifically hybridize to the amplified DNA will be detected
Sequence-Base-Typing
SBT
sequencing of PCR-amplified HLA genes
SBT can be carried out using Sanger dideoxy chain terminator sequencing. A generic amplification of the HLA gene of interest is conducted, followed by a sequencing reaction using dideoxy nucleotides. The dideoxy terminators are fluorescently labeled. Incorporation into the synthesized DNA molecule is detected using automated DNA sequencers with fluorescent detectors. The sequence of the target gene is compared with an HLA sequence database to determine the specific HLA allele for the patient.
HLA genotyping advantages over CDC
Higher resolution
Reagent quality
High throughput
HLA Ab may develop in response to
multiple blood transfusions, prior organ transplants, paternally derived fetal Ag by pregnant women
HLA Ab can cause
Hyperacute graft rejection
Donors with HLA Ag that can react with the Ab in a transplant candidate should be eliminated from consideration
ELISA testing for HLA Ab
purified HLA Ag bound to microtiter wells
incubated with serum
Crossmatching
donor-recipient CDC test done to confirm the absence of donor-specific Ab
Flow Cytometry for HLA Ab
Pt serum incubated with mixture of beads coated with different HLA proteins
washed, add FITC-labeled anti-IgG
Wash; analyze fluorescence by flow cytometry
Post-transplant testing
monitoring
HLA Ab testing
solid organ transplants
bead array assay
Chimerism
HSC transplants
PCR amplification of STRs